檢索結果 - Bertrand Cariou
- Showing 1 - 20 results of 93
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program... 由 Michel Farnier, Daniel Gaudet, Velichka Valcheva, Pascal Minini, Kathryn Miller, Bertrand Cariou
出版 2016Artigo -
9
-
10
-
11
-
12
Treatment intensification with an insulin degludec (<scp>IDeg</scp>)/insulin aspart (<scp>IAsp</scp>) co‐formulation twice daily compared with basal <scp>IDeg</scp> and prandial <s... 由 Helena W. Rodbard, Bertrand Cariou, Thomas R. Pieber, Lars Endahl, Jeppe Zacho, John Graham Cooper
出版 2015Artigo -
13
-
14
-
15
-
16
-
17
-
18
Comparison of insulin degludec with insulin glargine in insulin‐naive subjects with Type 2 diabetes: a 2‐year randomized, treat‐to‐target trial 由 Helena W. Rodbard, Bertrand Cariou, Bernard Zinman, Yehuda Handelsman, Athena Philis‐Tsimikas, Trine Vang Skjøth, Ashma Rana, Chantal Mathieu
出版 2013Artigo -
19
-
20
A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (<scp>BEGIN</scp>: <scp>VICTOZA ADD‐ON</scp>) 由 Chantal Mathieu, Helena W. Rodbard, Bertrand Cariou, Yehuda Handelsman, Athena Philis‐Tsimikas, Ann Marie Ocampo Francisco, Ashma Rana, Bernard Zinman
出版 2014Artigo
相關主題
Medicine
Internal medicine
Endocrinology
Diabetes mellitus
Type 2 diabetes
Biology
Cholesterol
Insulin
Lipoprotein
Chemistry
LDL receptor
PCSK9
Biochemistry
Disease
Insulin resistance
Pathology
Alternative medicine
Placebo
Gene
Apolipoprotein A1
Environmental health
Familial hypercholesterolemia
Gastroenterology
Population
Alirocumab
Randomized controlled trial
Apolipoprotein B
Glucose homeostasis
Pharmacology
Coronavirus disease 2019 (COVID-19)